The degree of tauopathy in the brain correlates with the cognitive decline in AD, suggesting that spreading of Tau deposits could be associated with disease progression (Braak & Braak, 1991; Braak et al, 2011). The gene discussed is MAPT; the disease is Alzheimer disease.